Diffusion Tensor Imaging (DTI) is an advanced imaging technique that is widely used to assess tissue integrity, structural connectivity, and microstructural properties of white matter (WM) in the human brain. DTI is based on the theory that water diffuses differently depending on the tissue it passed through, and so tracking the diffusion can provide information about the environment through which the water diffused. It is becoming increasingly important in the clinical setting, as it allows for detailed mapping of a tissue's structure and connectivity, as well as providing information about the underlying neuropathology. The most common DTI acquisition method, diffusion-weighted imaging (DWI), collects data at multiple orientations of the diffusion gradients, allowing for a 3-dimensional reconstruction of the underlying tissue. Based on the results from the DWI scans, the direction of the main diffusion tensor can be determined. This tensor can then be used to identify abnormalities in the regional white matter which can be indicative of neuropathology or injury. DTI can also be used to measure structural connectivity between areas by calculating parameters such as fiber tract length and diffusion anisotropy. This is important in neuroscience, as it allows for the study of the functionality and organization of WM tracts. DTI can also be used to compare documentation between healthy and diseased tissue, providing a more comprehensive evaluation than conventional MRI. In summary, DTI is an important imaging tool for the study of microstructural properties and connectivity of the human brain.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom